Mark Kowalski
2013 - Arbutus Biopharma Corp
In 2013, Mark Kowalski earned a total compensation of $430.5K as Chief Medical Officer at Arbutus Biopharma Corp.
Compensation breakdown
| Bonus | $36,240 |
|---|---|
| Option Awards | $261,819 |
| Salary | $128,623 |
| Other | $3,859 |
| Total | $430,541 |
Kowalski received $261.8K in option awards, accounting for 61% of the total pay in 2013.
Kowalski also received $36.2K in bonus, $128.6K in salary and $3.9K in other compensation.
Rankings
In 2013, Mark Kowalski's compensation ranked 9,834th out of 12,286 executives tracked by ExecPay. In other words, Kowalski earned more than 20.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,834 out of 12,286 | 20th |
Division Manufacturing | 3,654 out of 4,612 | 21st |
Major group Chemicals And Allied Products | 1,163 out of 1,466 | 21st |
Industry group Drugs | 908 out of 1,160 | 22nd |
Industry Pharmaceutical Preparations | 705 out of 890 | 21st |
Source: SEC filing on April 7, 2016.
Kowalski's colleagues
We found three more compensation records of executives who worked with Mark Kowalski at Arbutus Biopharma Corp in 2013.